Massimo Maiani

TL;DR: For the first time in a Tako‐tsubo patient with refractory cardiogenic shock, the use of ECLS treatment is reported in order to unload the heart, sustain circulation and end‐organ perfusion, and promote potential ventricular recovery.

TL;DR: This study provides a proof‐of‐principle to the novel concept that genetically engineered grafted cells can be effectively employed as cell‐based vehicles for the local delivery of therapeutic cardiotropic substances, such as RLX, capable of improving adverse heart remodelling.

TL;DR: Coronary artery bypass surgery with CPB causes a significantly greater increase in NSE and S-100beta serum levels than off-pump surgery and correlates with cardiopulmonary bypass (CPB) duration.

TL;DR: In patients with mild to moderate mitral regurgitation, CABG alone may be performed with good overall survival, but with lower event-free survival than those undergoing concomitant mitral valve repair.

TL;DR: The use of composite arterial grafts provides excellent clinical and angiographic results, with a low rate of angina recurrence and late cardiac events, and these configurations allow for complete arterial revascularization.